Fertility and Sterility
Volume 91, Issue 2 , Pages 432-439 , February 2009

Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women

  • Swati K. Achrekar, M.Sc.

      Affiliations

    • National Institute for Research in Reproductive Health, Mumbai, India
    • ,
  • Deepak N. Modi, Ph.D.

      Affiliations

    • National Institute for Research in Reproductive Health, Mumbai, India
    • ,
  • Sadhana K. Desai, M.D.

      Affiliations

    • Fertility Clinic, Mumbai, India
    • ,
  • Vijay S. Mangoli, Ph.D.

      Affiliations

    • Fertility Clinic, Mumbai, India
    • ,
  • Ranjana V. Mangoli, M.Sc.

      Affiliations

    • Fertility Clinic, Mumbai, India
    • ,
  • Smita D. Mahale, Ph.D.

      Affiliations

    • National Institute for Research in Reproductive Health, Mumbai, India
    • Corresponding Author InformationReprint requests: Smita D. Mahale, Ph.D., National Institute for Research in Reproductive Health, J M Street, Parel, Mumbai, India (FAX: 91-22-24139412).

Received 21 September 2007 ,Revised 30 November 2007 ,Accepted 30 November 2007.

References 

  1. Develioglu OH, Cox B, Toner JP, Oehninger S, Muasher SJ. The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone. Hum Reprod. 1999;14:1168–1174
  2. Tinkanen H, Blauer M, Laippala P, Tuohimaa P, Kujansuu E. Prognostic factors in controlled ovarian hyperstimulation. Fertil Steril. 1999;72:932–936
  3. Scott RT, Leonardi MR, Hofmann GE, Illions EH, Neal GS, Navot D. A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population. Obstet Gynecol. 1993;82:539–544
  4. Scott RT, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril. 1995;63:1–11
  5. Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril. 1995;64:991–994
  6. Barnhart K, Osheroff J. Follicle stimulating hormone as a predictor of fertility. Curr Opin Obstet Gynecol. 1998;10:227–232
  7. Balasch J, Creus M, Fabregues F, Carmona F, Casamitjana R, Ascaso C, et al. Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am J Obstet Gynecol. 1996;175:1226–1230
  8. Evers JL, Slaats P, Land JA, Dumoulin JC, Dunselman GA. Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. Fertil Steril. 1998;69:1010–1014
  9. Hall JE, Welt CK, Cramer DW. Inhibin A and Inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod. 1999;14:409–415
  10. Dias JA, Cohen BD, Lindau-Shepard B, Nechamen CA, Peterson AJ, Schmidt A. Molecular, structural, and cellular biology of follitropin and follitropin receptor. Vitam Horm. 2002;64:249–322
  11. Means AR, Dedman JR, Tash JS, Tindall DJ, van Sickle M, Welsh MJ. Regulation of the testis Sertoli cell by follicle stimulating hormone. Annu Rev Physiol. 1980;42:59–70
  12. Simoni M, Gromoll J, Nieschlag E. The follicle stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev. 1997;18:739–773
  13. Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary–gonadal function. Endocr Rev. 2000;21:551–583
  14. Rannikko A, Pakarinen P, Manna PR, Beau I, Misrahi M, Aittomaki K, et al. Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation. Mol Hum Reprod. 2002;8:311–317
  15. Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, Pichard C, et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol. 1999;13:1844–1854
  16. Allen LA, Achermann JC, Pakarinen P, Kotlar TJ, Huhtaniemi IT, Jameson JL, et al. A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergondotrophic hypogonadism: clinical and molecular characteristics. Hum Reprod. 2003;18:251–256
  17. Doherty E, Pakarinen P, Tiitinen A, Kiilavuori A, Huhtaniemi I, Forrest S, et al. A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J Clin Endocrinol Metab. 2002;87:1151–1155
  18. Meduri G, Touraine P, Beau I, Lahuna O, Desroches A, Vacher-Lavenu MC, et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J Clin Endocrinol Metab. 2003;88:3491–3498
  19. Simoni M, Nieschlag E, Gromoll J. Isoforms and single nucleotide polymorphisms of FSH receptor gene: implications for human reproduction. Hum Reprod Update. 2002;8:413–421
  20. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000;85:3365–3369
  21. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P, et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics. 2005;15:451–456
  22. Daelemans C, Smits G, de Maertelaer V, Costagliola S, Englert Y, Vassart G, et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab. 2004;89:6310–6315
  23. Peter PR. Ovarian follicular stimulation reigns in ART: the Bourn Hall Experience. In:  Kamini R editors. The Infertility Manual. India: Jaypee (FOGSI) Publication; 2004;p. 293–303
  24. Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S. Genetic and functional analyses of polymorphism in the human FSH receptor gene. Mol Hum Reprod. 2002;8:893–899
  25. Laven JS, Mulders AG, Suryandari DA, Gromoll J, Nieschlag E, Fauser BC, et al. Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril. 2003;8:986–992
  26. Greb RR, Grieshaber K, Gromoll J, Sonntag B, Nieschlag E, Kiesel L, et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab. 2005;90:4866–4872
  27. Loutradis D, Patsoula E, Minas V, Koussidis GA, Antsaklis A, Michalas S, et al. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet. 2006;23:177–184
  28. Fauser BC, Devroey P, Yen SS, Gosden R, Crowley WF, Baird DT, et al. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod. 1999;14:2681–2686
  29. Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome—views and ideas. Hum Reprod. 1997;12:1129–1137
  30. d'Alva CB, Serafini P, Motta E, Kohek MB, Latronico AC, Mendonca BB. Absence of follicle-stimulating hormone receptor activating mutations in women with iatrogenic ovarian hyperstimulation syndrome. Fertil Steril. 2005;83:1695–1699
  31. Kerkela E, Skottman H, Friden B, Bjuresten K, Kere J, Hovatta O. Exclusion of coding-region mutations in luteinizing hormone and follicle-stimulating hormone receptor genes as the cause of ovarian hyperstimulation syndrome. Fertile Steril. 2007;87:603–606
  32. Kene PS, Nalavadi VC, Dighe RR, Iyer KS, Mahale SD. Identification of structural and functional determinants of the extracellular domain of the human follicle stimulating hormone receptor. J Endocrinol. 2004;182:501–508
  33. Kene PS, Dighe RR, Mahale SD. Delineation of regions in the extracellular domain of follicle-stimulating hormone receptor involved in hormone binding and signal transduction. Am J Reprod Immunol. 2005;54:38–48
  34. Ryan GL, Feng X, d'Alva CB, Zhang M, Van Voorhis BJ, Pinto EM, et al. Evaluating the roles of follicle-stimulating hormone receptor polymorphisms in gonadal hyperstimulation associated with sever juveile primary hypothyrodism. J Clin Endocrinol Metab. 2007;92:2312–2317
  35. Klinkert ER, te Velde ER, Weima S, van Zandvoort PM, Hanssen RG, Nilsson PR, et al. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online. 2006;13:687–695

 S.K.A. has nothing to disclose. D.N.M. has nothing to disclose, S.K.D. has nothing to disclose. V.S.M. has nothing to disclose. R.V.M. has nothing to disclose. S.D.M. has nothing to disclose.

 Supported by grants from National Institute for Research in Reproductive Health, Mumbai (NIRRH/MS/3/2007) and from Indian Council of Medical Research (63/116/2001-BMS II), New Delhi, India.

PII: S0015-0282(07)04182-9

doi: 10.1016/j.fertnstert.2007.11.093

Fertility and Sterility
Volume 91, Issue 2 , Pages 432-439 , February 2009

Article Tools

* Image Usage & Resolution